Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF) (click to learn more) Why Herbal Dispatch (CSE:HERB) Is Getting Attention (click to learn more) Atlas Salt Expands MOU with Sandvik Mining Supporting Great Atlantic Salt Project (click to learn more) Digital Health Meets AI -CSE: ALEN.U (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Curative Biotechnology Inc (ID) CUBT

Healthcare Biotechnology
Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular degeneration and geographic atrophy; IMT504, a novel immunotherapy to treat late-stage rabies; and CUBT906, a fully humanized CD56 monoclonal antibody... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News ()

Curative Biotechnology Announces Canadian Patent Allowance

GlobeNewswire January 23, 2026

Curative Biotechnology, Inc. Announces Letter to Shareholders

GlobeNewswire November 18, 2025

Curative Biotechnology, Inc. Engages Golden Eagle Capital Advisors, Inc. as Exclusive Agent and Strategic Advisor

GlobeNewswire December 13, 2024

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors

GlobeNewswire March 22, 2024

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors

GlobeNewswire January 8, 2024

Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors

GlobeNewswire October 31, 2023

Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions

GlobeNewswire June 6, 2023

Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation

GlobeNewswire May 24, 2023

Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study

GlobeNewswire January 5, 2023
View More News ››

Opinion & Analysis ()

No current opinion is available.
View More Opinion ››

Bullboard Posts ()

TGIFF 1933 Industries - Nevada dispensaries everywhere...

TGIFF – 1933 Ind. 2021 AMA Dispensary Drops in Las Vegas and Nevada Deliveries of flower, concentrates, badder, diamonds, exotics...
INVESTigator1 - May 9, 2021

Hurry up!

If CTYX is watching this sight; I don't like the vaccines coming out. Theraputics much better. Hurry up.
slowandeasy - December 24, 2020
View more Bullboard ››

Blue Sky Uranium Corp.

Blue Sky Uranium Corp.

Blue Sky Uranium Corp., a junior uranium exploration company, engages in the acquisition, exploration, and evaluation of ...
View More »

Podcasts